Trial
NCT00963872
Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Leukemia
Intervention
cyclophosphamide
Why stopped
Lack of efficacy after interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-28